Form D · Pharmaceuticals
Zavante Therapeutics, Inc.
San Diego, CA · CIK 0001642422
Offering snapshot reported Apr 4, 2016 · SEC filing
- Reported sold
- $45.7M Offering amount: $45.7M
- Investors reported
- 54 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 24, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 4, 2016 | Initial | $45,731,764 | No comparison | 54 | SEC filing |
| Dec 22, 2015 | Amendment | $10,283,486 | $6,098,623vs Jul 1, 2015 | 48 | SEC filing |
| Jul 1, 2015 | Initial | $4,184,863 | No comparison | 28 | SEC filing |
| May 15, 2015 | Initial | $14,200 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-260605
Source: Form D, filed Apr 4, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Evelyn J. Ellis Grosse | Executive |
| Kevin Finney | Executive |
| Cam Gallagher | Executive |
| Cam L. Garner | Director, Executive |
| Patrick Heron | Director |
| David Hirsch | Director |
| Theodore R. Schroeder | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
12670 High Bluff Drive
San Diego, CA, 92130
San Diego, CA, 92130